Atomwise’s AIMS Initiative Proves AtomNet AI Platform as a Superior Alternative to Traditional High-Throughput Screening in Drug Discovery – Draper Decentralized – 6.3.24
Atomwise has revealed significant findings from its AIMS (Artificial Intelligence Molecular Screen) initiative, proving the AtomNet AI Platform as a strong alternative to traditional high-throughput screening for drug discovery. Published in Nature Scientific Reports, the study showed AtomNet identified structurally novel hits for 235 targets, greatly improving hit success rates compared to traditional HTS.
